{Reference Type}: Journal Article
{Title}: Acquired ductopenia: an insight into imaging findings.
{Author}: Khot R;Shelman NR;Ludwig DR;Nair RT;Anderson MA;Venkatesh SK;Paspulati RM;Parker RA;Menias CO;
{Journal}: Abdom Radiol (NY)
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 2
暂无{DOI}: 10.1007/s00261-024-04462-x
{Abstract}: Hepatic ductopenia is a pathologic diagnosis characterized by a decrease in the number of intrahepatic bile ducts as a consequence of various underlying etiologies. Some etiologies, such as primary sclerosing cholangitis, primary biliary cholangitis, and ischemic cholangitis, often have distinctive imaging findings. In contrast, other causes such as chronic rejection following liver transplantation, drug-induced biliary injury, infection, malignancy such as lymphoma, and graft-versus-host disease may only have ancillary or non-specific imaging findings. Thus, diagnosing ductopenia in conditions with nonspecific imaging findings requires a multidimensional approach, including clinical evaluation, serological testing, imaging, and liver histology to identify the underlying cause. These etiologies lead to impaired bile flow, resulting in cholestasis, liver dysfunction, and, ultimately, cirrhosis and liver failure if the underlying cause remains untreated or undetected. In the majority of instances, individuals diagnosed with ductopenia exhibit a positive response to treatment addressing the root cause or cessation of the causative agent. This article focuses on acquired causes of ductopenia, its clinical manifestation, histopathology, imaging diagnosis, and management.